Effect of MAGE-C1 Gene Expression on Prognosis and Effectiveness of Bortezomib-Containing Courses in Multiple Myeloma
E. A. Makunina, Savchenko Vg(National Research Center for Hematology Russian Academy of Medical Sciences), В. Л. Сурин(National Medical Research Center for Hematology), Л. П. Менделеева(National Research Center for Hematology Russian Academy of Medical Sciences), Julia O. Davidova(National Medical Research Center for Hematology), Maxim Solovev(National Medical Research Center for Hematology), Maiia V. Firsova(National Medical Research Center for Hematology), Irina Galtseva(National Research Center for Preventive Medicine)
Cited by 0
Related Papers
Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow Transplantation
|Bone Marrow Transplantation|2014|195
Atlas of RNA sequencing profiles for normal human tissues
|Scientific Data|2019|142
Current Multiple Myeloma Treatment Strategies with Novel Agents: A European Perspective
|The Oncologist|2010|92
Thromboelastography, thrombin generation test and thrombodynamics reveal hypercoagulability in patients with multiple myeloma
|Leukemia & lymphoma/Leukemia and lymphoma|2015|59